FDA Drug Application (201189) for REPAGLINIDE by PADDOCK LLC

Back to FDA Applications sponsored by PADDOCK LLC

Application Number201189
Product Number001
FormTABLET;ORAL
Dosage0.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameREPAGLINIDE
Active IngredientREPAGLINIDE

Active IngredientCount
List of drugs with Active Ingredient REPAGLINIDE4


Back to FDA Applications sponsored by PADDOCK LLC